Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA

K-Number: K884962 · 1990-02-09

ApplicantBausch & Lomb Pharmaceutical, Inc.
Decision Date1990-02-09
Product CodeMOE
Advisory CommitteeOP
DecisionSubstantially Equivalent

Device Summary

ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA is the device name listed in this FDA 510(k) record. The listed applicant is Bausch & Lomb Pharmaceutical, Inc.. It received FDA 510(k) clearance on 1990-02-09 under 510(k) number K884962. The device is classified under product code MOE. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA?

ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA is a medical device that received FDA 510(k) clearance on 1990-02-09. The listed applicant is Bausch & Lomb Pharmaceutical, Inc.. The 510(k) number is K884962.

When did ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA receive FDA 510(k) clearance?

ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA received FDA 510(k) clearance on 1990-02-09, under 510(k) number K884962.

Who is the listed applicant for ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA?

The FDA 510(k) record lists Bausch & Lomb Pharmaceutical, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA?

The FDA product code for ADDIT. INDICATIONS FOR BIO-COR EXT COLLAGEN CORNEA is MOE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Bausch & Lomb Pharmaceutical, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K884960ADDIT. INDICATION FOR FYODOROV COLLAGEN CORNEALK884961ADDIT. INDICATIONS FOR BIO-COR II COLLAGEN CORNEALK884363LABELING CHANGES TO BIO-COR II COLLANGEN CORNEALK884362LABELING CHANGES TO FYODOROV COLLAGEN CORNEAL SHLDK884364LABELING CHANGES TO BIO-COR EXT COLLANGEN CORNEAL

Related Devices (Code: MOE)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K944872BIO-COR COLLAGEN CORNEAL SHIELDBausch & Lomb Healthcare and Optics WorldwideK915861MEDILENS-CS CORNEAL SHIELDChiron OphthalmicsK914529SOFTSHIELD(TM) 12, 24, 72 COLLAGEN CORNEAL SHIELDSOasis Medical, Inc.K913148COLLAGEN SHIELD FOR ACUTE CAREVitaphore Corp.K905825COLLAGEN SHIELD, VARIOUS MODELSChiron OphthalmicsK902558COLLAGEN SHIELD FOR ACUTE CAREVitaphore Corp.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑